Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy
Medical Review · 26.10.2023 · 3 (5) · 444-447
DOI: 10.1515/mr-2023-0029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Review, online erschienen am 20.09.2023. Verfasst von Quazi T H Shubhra. Beteiligte Einrichtung: Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Iron oxide (IO) nanoparticles (NPs) have gained significant attention in the field of biomedicine, particularly in drug targeting and cancer therapy. Their potential in magnetic drug targeting (MDT) and ferroptosis-based cancer therapy is highly promising. IO NPs serve as an effective drug delivery system (DDS), utilizing external magnetic fields (EMFs) to target cancer cells while minimizing damage to healthy organs. Additionally, IO NPs can generate reactive oxygen species (ROS) and induce ferroptosis, resulting in cytotoxic effects on cancer cells. This article explores how IO NPs can potentially revolutionize cancer research, focusing on their applications in MDT and ferroptosis-based therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
- Institute of Chemistry, University of Silesia in Katowice Chorzów, Poland.
ORCID-Profile: Quazi T H Shubhra
Zitieren
APA
Shubhra, Q. T. H. (2023). Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy. Medical Review, 3(5), 444-447. https://doi.org/10.1515/mr-2023-0029
Vancouver
Shubhra QTH. Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy. Medical Review. 2023;3(5):444-447. doi:10.1515/mr-2023-0029
BibTeX
@article{Shubhra2023,
author = {Shubhra, Quazi T H},
title = {Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy},
journal = {Medical Review},
year = {2023},
volume = {3},
number = {5},
pages = {444--447},
doi = {10.1515/mr-2023-0029}
}
EUVIMED